BioSpace News Archive

ALRT Partners with Bionime Corporation to Offer Comprehensive Diabetes Solution at Lower Cost Than Test Supplies Alone Available in Pharmacy Chains

Singer/songwriter Crystal Bowersox kicks off the educational initiative by encouraging people to educate their support network and develop a plan for low blood sugar and very low blood sugar emergencies

DelMar Pharmaceuticals Receives $500,000 Loan from the NBTS and NFCR to Support VAL-083’s Participation in a Pivotal Study for Glioblastoma Sponsored by the Global Coalition for Adaptive Research

NeuroSigma, Inc., a Los Angeles-based bioelectronics company focused on commercializing Trigeminal Nerve Stimulation (TNS) technology for treating neurological and neuropsychiatric disorders today announced that results from a randomized controlled trial of external Trigeminal Nerve Stimulation (eTNS®) for treating drug resistant epilepsy (DRE) were published in the June 2020 issue of the journal Brain Stimulation.

Nearly half of breastfeeding moms are concerned about workplace pumping accommodations due to COVID-19

In celebration of Healthy Vision Month this July, Versant Health has launched a new resource center providing tools that enable people to take command of their vision health—an important, but often overlooked, indicator of overall health and wellness.

Analysis of treatment outcomes in five severe COVID-19 patients showed substantial benefit to patients treated with opaganib under compassionate use in both clinical outcomes and inflammatory markers as compared to a matched case-control group from the same hospital

Quest Products, LLLC. (Quest) today announced its acquisition of Summit Pharmaceuticals / Alliance Labs. Quest is a portfolio company of Promus Equity Partners (Promus).

Biomerics, LLC, a mid-market medical device contract manufacturer specializing in interventional and radiology markets, launched an online store to sell medical balloons. This new e-Commerce platform will sell a range of off-the-shelf Nylon, PET, and LDPE medical balloons. The fast-turn store enables engineers to develop and prototype

Xenocor, Inc., a privately held company focused on identifying, developing and commercializing innovative and differentiated endoscopes to address significant unmet needs in making minimally invasive approaches more accessible at a lower cost, is pleased to announce that the United States Patent and Trademark Office (USPTO) is scheduled to issue Xenocor U.S. Patent No. 10,702,128 on July 7, 2020.